We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Seeks Improved Risk Oversight Through Reorganization
FDA Seeks Improved Risk Oversight Through Reorganization
June 30, 2006
The FDA is attempting to improve regulatory compliance and reduce risk by reorganizing the Office of Regulatory Affairs (ORA), an agency memorandum says.